Immunothearpy for the Treatment of Multiple Myeloma

Expected survival rates are rapidly increasing for myeloma but the relapse burden is the major obstacle to obtaining long-term remission and maybe even cure. Like many other hematological malignancies immunotherapies emerged as a very promising approach and new studies are eagerly awaited. Despite marked success with many new agents’ safety remains a major concern as [...]